July 1, 2014 – L.O.M. Medical International Inc. (“LOM” or the “Company “) The Company is pleased to announce that it has completed its final tranche of the Convertible Debenture.
In total, the Company has issued notes for a gross amount of $2,000,000. The Debentures will bear interest at a rate of 8.00% per annum, payable semi-annually from the Closing Date.
The debentures may be converted into common shares of the Company at a price of $5.00 at any time at the election of the note holder for up to 24 months.
Herbert Towning, President and CEO states, “With the closing of this final tranche L.O.M. will continue to use the investments to further the development of its revolutionary technology. The funds raised have allowed us to deal with much of the Company’s accrued past debts and we are now in a much stronger position to move forward with the business of working with the requirements of our targeted acquirer companies.”
The Company has also recently settled with past debt holders in a transaction that will settle old debts with shareholders. The debt holders were offered Units for Debt at a value of $5 per Unit, Each Unit consists of one common share in the Company and one share purchase warrant at an exercise price of $5.00 per share exercisable for up to 24 months from the date of issue.